世界の橋本甲状腺炎治療薬市場2020:企業別、地域別、種類別、用途別、市場予測2025

GlobalInfoResearchが発行した調査報告書(GIR20OC13728)
◆英語タイトル:Global Hashimotos Thyroiditis Drug Market 2020 by Company, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20OC13728
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年10月(※2024年版があります。お問い合わせください。)
◆ページ数:105
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本書では、橋本甲状腺炎治療薬の世界市場を調査対象にし、橋本甲状腺炎治療薬の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(カプセル、錠剤、粉末)、用途別分析(病院薬局、小売薬局、オンライン薬局)、市場予測(2021年~2025年)情報などを整理しました。
・市場概要
・企業情報:LGM Pharma、Menarini、Jerome Stevens Pharmaceuticals、Merck、Shenzhen Zhonglian Pharmaceutical、Sichuan Hairong Pharmaceutical、Manus Aktteva、Pfizer、Novartis
・企業別売上、市場シェア
・橋本甲状腺炎治療薬の地域別市場分析
・橋本甲状腺炎治療薬の北米市場規模2015-2020:アメリカ、カナダ、メキシコ
・橋本甲状腺炎治療薬のヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど
・橋本甲状腺炎治療薬のアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど
・橋本甲状腺炎治療薬の南米市場規模2015-2020:ブラジル、アルゼンチンなど
・橋本甲状腺炎治療薬の中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど
・橋本甲状腺炎治療薬の種類別市場規模2015-2020:カプセル、錠剤、粉末
・橋本甲状腺炎治療薬の用途別市場規模2015-2020:病院薬局、小売薬局、オンライン薬局
・橋本甲状腺炎治療薬の世界市場予測2021-2025:地域別、種類別、用途別
・調査の結果・結論
【レポートの概要】

Market Overview
The global Hashimotos Thyroiditis Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Hashimotos Thyroiditis Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Hashimotos Thyroiditis Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Hashimotos Thyroiditis Drug market has been segmented into:
Capsule
Tablet
Powder

By Application, Hashimotos Thyroiditis Drug has been segmented into:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Hashimotos Thyroiditis Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Hashimotos Thyroiditis Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Hashimotos Thyroiditis Drug market.

The report offers in-depth assessment of the growth and other aspects of the Hashimotos Thyroiditis Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Hashimotos Thyroiditis Drug Market Share Analysis
Hashimotos Thyroiditis Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Hashimotos Thyroiditis Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Hashimotos Thyroiditis Drug sales, revenue and market share for each player covered in this report.

The major players covered in Hashimotos Thyroiditis Drug are:
LGM Pharma
Menarini
Jerome Stevens Pharmaceuticals
Merck
Shenzhen Zhonglian Pharmaceutical
Sichuan Hairong Pharmaceutical
Manus Aktteva
Pfizer
Novartis

【レポートの目次】

Table of Contents

1 Hashimotos Thyroiditis Drug Market Overview
1.1 Product Overview and Scope of Hashimotos Thyroiditis Drug
1.2 Classification of Hashimotos Thyroiditis Drug by Type
1.2.1 Global Hashimotos Thyroiditis Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Hashimotos Thyroiditis Drug Revenue Market Share by Type in 2019
1.2.3 Capsule
1.2.4 Tablet
1.2.5 Powder
1.3 Global Hashimotos Thyroiditis Drug Market by Application
1.3.1 Overview: Global Hashimotos Thyroiditis Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Hashimotos Thyroiditis Drug Market by Regions
1.4.1 Global Hashimotos Thyroiditis Drug Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Hashimotos Thyroiditis Drug (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Hashimotos Thyroiditis Drug Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Hashimotos Thyroiditis Drug Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hashimotos Thyroiditis Drug Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Hashimotos Thyroiditis Drug Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hashimotos Thyroiditis Drug Status and Prospect (2015-2025)
2 Company Profiles
2.1 LGM Pharma
2.1.1 LGM Pharma Details
2.1.2 LGM Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 LGM Pharma SWOT Analysis
2.1.4 LGM Pharma Product and Services
2.1.5 LGM Pharma Hashimotos Thyroiditis Drug Revenue, Gross Margin and Market Share (2018-2019)
2.2 Menarini
2.2.1 Menarini Details
2.2.2 Menarini Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Menarini SWOT Analysis
2.2.4 Menarini Product and Services
2.2.5 Menarini Hashimotos Thyroiditis Drug Revenue, Gross Margin and Market Share (2018-2019)
2.3 Jerome Stevens Pharmaceuticals
2.3.1 Jerome Stevens Pharmaceuticals Details
2.3.2 Jerome Stevens Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Jerome Stevens Pharmaceuticals SWOT Analysis
2.3.4 Jerome Stevens Pharmaceuticals Product and Services
2.3.5 Jerome Stevens Pharmaceuticals Hashimotos Thyroiditis Drug Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck SWOT Analysis
2.4.4 Merck Product and Services
2.4.5 Merck Hashimotos Thyroiditis Drug Revenue, Gross Margin and Market Share (2018-2019)
2.5 Shenzhen Zhonglian Pharmaceutical
2.5.1 Shenzhen Zhonglian Pharmaceutical Details
2.5.2 Shenzhen Zhonglian Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Shenzhen Zhonglian Pharmaceutical SWOT Analysis
2.5.4 Shenzhen Zhonglian Pharmaceutical Product and Services
2.5.5 Shenzhen Zhonglian Pharmaceutical Hashimotos Thyroiditis Drug Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sichuan Hairong Pharmaceutical
2.6.1 Sichuan Hairong Pharmaceutical Details
2.6.2 Sichuan Hairong Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Sichuan Hairong Pharmaceutical SWOT Analysis
2.6.4 Sichuan Hairong Pharmaceutical Product and Services
2.6.5 Sichuan Hairong Pharmaceutical Hashimotos Thyroiditis Drug Revenue, Gross Margin and Market Share (2018-2019)
2.7 Manus Aktteva
2.7.1 Manus Aktteva Details
2.7.2 Manus Aktteva Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Manus Aktteva SWOT Analysis
2.7.4 Manus Aktteva Product and Services
2.7.5 Manus Aktteva Hashimotos Thyroiditis Drug Revenue, Gross Margin and Market Share (2018-2019)
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Pfizer SWOT Analysis
2.8.4 Pfizer Product and Services
2.8.5 Pfizer Hashimotos Thyroiditis Drug Revenue, Gross Margin and Market Share (2018-2019)
2.9 Novartis
2.9.1 Novartis Details
2.9.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Novartis SWOT Analysis
2.9.4 Novartis Product and Services
2.9.5 Novartis Hashimotos Thyroiditis Drug Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Hashimotos Thyroiditis Drug Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Hashimotos Thyroiditis Drug Players Market Share
3.2.2 Top 10 Hashimotos Thyroiditis Drug Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Hashimotos Thyroiditis Drug Revenue and Market Share by Regions
4.2 North America Hashimotos Thyroiditis Drug Revenue and Growth Rate (2015-2020)
4.3 Europe Hashimotos Thyroiditis Drug Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Hashimotos Thyroiditis Drug Revenue and Growth Rate (2015-2020)
4.5 South America Hashimotos Thyroiditis Drug Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Hashimotos Thyroiditis Drug Revenue and Growth Rate (2015-2020)
5 North America Hashimotos Thyroiditis Drug Revenue by Countries
5.1 North America Hashimotos Thyroiditis Drug Revenue by Countries (2015-2020)
5.2 USA Hashimotos Thyroiditis Drug Revenue and Growth Rate (2015-2020)
5.3 Canada Hashimotos Thyroiditis Drug Revenue and Growth Rate (2015-2020)
5.4 Mexico Hashimotos Thyroiditis Drug Revenue and Growth Rate (2015-2020)
6 Europe Hashimotos Thyroiditis Drug Revenue by Countries
6.1 Europe Hashimotos Thyroiditis Drug Revenue by Countries (2015-2020)
6.2 Germany Hashimotos Thyroiditis Drug Revenue and Growth Rate (2015-2020)
6.3 UK Hashimotos Thyroiditis Drug Revenue and Growth Rate (2015-2020)
6.4 France Hashimotos Thyroiditis Drug Revenue and Growth Rate (2015-2020)
6.5 Russia Hashimotos Thyroiditis Drug Revenue and Growth Rate (2015-2020)
6.6 Italy Hashimotos Thyroiditis Drug Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Hashimotos Thyroiditis Drug Revenue by Countries
7.1 Asia-Pacific Hashimotos Thyroiditis Drug Revenue by Countries (2015-2020)
7.2 China Hashimotos Thyroiditis Drug Revenue and Growth Rate (2015-2020)
7.3 Japan Hashimotos Thyroiditis Drug Revenue and Growth Rate (2015-2020)
7.4 Korea Hashimotos Thyroiditis Drug Revenue and Growth Rate (2015-2020)
7.5 India Hashimotos Thyroiditis Drug Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Hashimotos Thyroiditis Drug Revenue and Growth Rate (2015-2020)
8 South America Hashimotos Thyroiditis Drug Revenue by Countries
8.1 South America Hashimotos Thyroiditis Drug Revenue by Countries (2015-2020)
8.2 Brazil Hashimotos Thyroiditis Drug Revenue and Growth Rate (2015-2020)
8.3 Argentina Hashimotos Thyroiditis Drug Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Hashimotos Thyroiditis Drug by Countries
9.1 Middle East & Africa Hashimotos Thyroiditis Drug Revenue by Countries (2015-2020)
9.2 Saudi Arabia Hashimotos Thyroiditis Drug Revenue and Growth Rate (2015-2020)
9.3 UAE Hashimotos Thyroiditis Drug Revenue and Growth Rate (2015-2020)
9.4 Egypt Hashimotos Thyroiditis Drug Revenue and Growth Rate (2015-2020)
9.5 South Africa Hashimotos Thyroiditis Drug Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Hashimotos Thyroiditis Drug Revenue and Market Share by Type (2015-2020)
10.2 Global Hashimotos Thyroiditis Drug Market Forecast by Type (2019-2024)
10.3 Capsule Revenue Growth Rate (2015-2025)
10.4 Tablet Revenue Growth Rate (2015-2025)
10.5 Powder Revenue Growth Rate (2015-2025)
11 Global Hashimotos Thyroiditis Drug Market Segment by Application
11.1 Global Hashimotos Thyroiditis Drug Revenue Market Share by Application (2015-2020)
11.2 Hashimotos Thyroiditis Drug Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2015-2020)
11.4 Retail Pharmacies Revenue Growth (2015-2020)
11.5 Online Pharmacies Revenue Growth (2015-2020)
12 Global Hashimotos Thyroiditis Drug Market Size Forecast (2021-2025)
12.1 Global Hashimotos Thyroiditis Drug Market Size Forecast (2021-2025)
12.2 Global Hashimotos Thyroiditis Drug Market Forecast by Regions (2021-2025)
12.3 North America Hashimotos Thyroiditis Drug Revenue Market Forecast (2021-2025)
12.4 Europe Hashimotos Thyroiditis Drug Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Hashimotos Thyroiditis Drug Revenue Market Forecast (2021-2025)
12.6 South America Hashimotos Thyroiditis Drug Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Hashimotos Thyroiditis Drug Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の橋本甲状腺炎治療薬市場2020:企業別、地域別、種類別、用途別、市場予測2025(Global Hashimotos Thyroiditis Drug Market 2020 by Company, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。